TCG Crossover GP II, LLC 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:27 pm Sale |
2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS |
TCG Crossover GP II, LLC | 2,470,265 5.000% |
-714,920 (-22.45%) |
Filing |
| 2024-02-15 4:20 pm Purchase |
2024-02-12 | 13G | Mineralys Therapeutics, Inc. MLYS |
TCG Crossover GP II, LLC | 3,185,185 6.400% |
3,185,185 (New Position) |
Filing |